Applied therapeutics to present at the 11th annual svb leerink global healthcare conference

New york, feb. 10, 2022 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present at the 11th annual svb leerink global healthcare conference on friday, february 18, 2022 at 11:20 a.m. et.
APLT Ratings Summary
APLT Quant Ranking